Genzyme will likely stall and stonewall until it gets a price that it wants, either from Sanofi-Aventis or a White Knight. Even Stonewall himself knew when to avoid stonewalling. Genzyme will need to justify a higher price if it expects to get one.
SPLS is holding higher inventories but for SPLS, customers are spending less -- a double whammy ...
URBN struggles to stay afloat among a sea of retail stocks. The real question is 'Why?"
NVIDIA (NASDAQ: NVDA) shares are trading up $0.62 or 6.5% to $9.50 after reporting second quarter earnings.
Macy's is one of the few stocks moving nicely today ...
The story over at SunPower continues to improve, as the company is cutting its costs as demand growth is accelerating.
DISH network revealed a dip in subscribers and Echostar reported a net loss ...
Shares of Priceline (NASDAQ: PCLN) are soaring in after hour trading, up $39.27 to $266.55 following an outstanding earnings report and raised guidance.
Online gaming is growing as more people don't go to work ...
Sentiment is bearish. Here are a look at some contrarian data points to consider before you get depressed ...
Second quarter earnings provide a clear glimpse into where the future of earnings growth is for the company, despite what appears to be slowing revenue growth.
Google misses EPS, reporting earnings of $6.45 vs consensus estimates of $6.51 on revenues of $5.09 billion against estimates of $5.0 billion.
Heavyweight Alcoa sets a good tune to the start of earnings season...
Is Rite Aid losing the war?
HP is well-managed, well-capitalized and clearly in a strong growth phase ...